Current options in IBD Management

Examining several sets of data and comparing phase results from different sets and blockers, discussing the finding of the trials as well as examining the data provided.

Biosimilars role in managing IBD and its long-term efficacy is elaborated. How COVID-19 affected IBD patients and what changes occurred after the pandemic that affected the treatment process.